ORGANIC
LETTERS
2012
Vol. 14, No. 22
5748–5751
Synthesis of the C1ꢀC26 Hexacyclic
Subunit of Pectenotoxin 2
Ozora Kubo, Daniel P. Canterbury, and Glenn C. Micalizio*
Department of Chemistry, The Scripps Research Institute, Jupiter, Florida 33458,
United States
Received October 5, 2012
ABSTRACT
Synthesis of the C1ꢀC26 hexacyclic subunit of pectenotoxin-2 (PTX-2) is described that features a stereoselective annulation to generate the
C-ring by triple asymmetric NozakiꢀHiyamaꢀKishi coupling followed by oxidative cyclization. Preparation of the C1ꢀC14 AB spriroketal-
containing subunit employs a recently developed metallacycle-mediated reductive cross-coupling between a TMS-alkyne and a terminal alkene.
Pectenotoxin-2 (PTX2) is araremarine-derivedpolyether
natural product that displays rather profound anticancer
properties (Figure 1A).1ꢀ3 Discovered in the digestive glands
of the scallop Patinopecten yessoensis4 and traced back to the
dinoflagellates Dinophysis fortii and D. acuminata,5 recent
studies have described the isolation of PTX2 from a two-
sponge association (Poecillastra sp. and Jaspis sp.).2 Initial
biological evaluation of PTX2 established its substantial
cytotoxic profile, with later studies concluding that this
natural product is a unique actin depolymerizing agent.
Binding to a site on G-actin that is distinct from other known
marine toxins,6 recent studies have determined that PTX2 is
selectively cytotoxic to p53 mutant and p53(ꢀ) cancers
(representing approximately 50% of all human cancers).1,7
While no laboratory synthesis of PTX2 has been
reported,8 a number of studies directed toward this goal
have appeared.9 Here, we describe an efficient assembly of
the C1ꢀC26 ABCDEF hexacyclic subunit of PTX2 (2) by
convergent union of the functionalized vinyliodide 3 with
the tricyclic acetal-containing aldehyde 4 (Figure 1B).
While these pursuits have led to the generation of a
substantial subunit of pectenotoxin-2 (2), they have also
defined an approach to stereodefined 2,2,5-trisubstituted
THFs based on double or triple asymmetric Nozakiꢀ
HiyamaꢀKishi (NHK) coupling (8 þ 9 f 7) and site
(8) For total syntheses of pectenotoxin-4 and -8, see: (a) Evans, D. A.;
Rajapakse, H. A.; Stenkamp, D. Angew. Chem., Int. Ed. 2002, 41,
4569–4573. (b) Evans, D. A.; Rajapakse, H. A.; Chiu, A.; Stenkamp, D.
Angew. Chem., Int. Ed. 2002, 41, 4573–4576.
(9) For partial synthesis and studies toward the syntheses of the
pectenotoxins, see: (a) Micalizio, G. C.; Roush, W. R. Org. Lett. 2001, 3,
1949–1952. (b) Paquette, L. A.; Peng, X.; Bondar, D. Org. Lett. 2002, 4,
937–940. (c) Pihko, P. M.; Aho, J. E. Org. Lett. 2004, 6, 3849–3852. (d)
(1) Chae, H.; Choi, T.; Kim, B.; Jung, J.; Bang, Y.; Shin, D. Y.
Oncogene 2005, 24, 4813–4819.
(2) Jung, J. H.; Sim, C. J.; Lee, C. J. Nat. Prod. 1995, 58, 1722–1726.
(3) Spector, I.; Braet, F.; Shochet, n. R.; Bubb, M. R. Microsc. Res.
Tech. 1999, 47, 18–37.
(4) (a) Yasumoto, T.; Murate, M.; Oshima, Y.; Sano, M.; Matsumoto,
G. K.; Clardy, J. Tetrahedron 1985, 41, 1019–1025. (b) Sasaki, K.; Wright,
J. L. C.; Yasumoto, T. J. Org. Chem. 1998, 63, 2475–2480. (c) Yasumoto,
T.; Murata, M. Chem. Rev. 1993, 93, 1897–1909.
(5) (a) Yasumoto, T.; Oshima, Y.; Sugawara, W.; Fukuyo, Y.; Oguri,
H.; Igarashi, T.; Fujita, N. Bull. Jpn. Soc. Sci. Fish. 1980, 46, 1405–1411.
(b) Lee, J.; Igarashi, T.; Fraga, S.; Dahl, E.; Hovgaard, P.; Yasumoto, T.
J. Appl. Phycol. 1989, 1, 147–152. (c) Draisci, R.; Lucentini, L.;
Giannetti, L.; Boria, P.; Poletti, R. Toxicon 1996, 34, 923–935.
(6) Allingham, J. S.; Miles, C. O.; Rayment, I. J. Mol. Bio. 2007, 371,
959–970.
€
Bondar, D.; Liu, J.; Muller, T.; Paquette, L. A. Org. Lett. 2005, 7, 1813–
1816. (e) Halim, R.; Brimble, M. A.; Merten, J. Org. Lett. 2005, 7, 2659–
2662. (f) Vellucci, D.; Rychnovsky, S. D. Org. Lett. 2007, 9, 711–714. (g)
O’Connor, P. D.; Knight, C. K.; Friedrich, D.; Peng, X.; Paquette, L. A.
J. Org. Chem. 2007, 72, 1747–1754. (h) Lotesta, S. D.; Hou, Y.; Williams,
L. J. Org. Lett. 2007, 9, 869–872. (i) Heapy, A. M.; Wagner, T. W.;
Brimble, M. M. Synlett 2007, 2359–2362. (j) Fujiwara, K.; Aki, Y.;
Yamamoto, F.; Kawamura, M.; Kobayashi, M.; Okano, A.; Awakura,
D.; Shiga, S.; Murai, A.; Kawai, H.; Suzuki, T. Tetrahedron Lett. 2007,
48, 4523–4527. (k) Kolakowski, R. V.; Williams, L. J. Tetrahedron Lett.
€
2007, 48, 4761–4764. (l) Aho, J. E.; Salomaki, E.; Rissanen, K.; Pihko,
P. M. Org. Lett. 2008, 10, 4179–4182. (m) Carley, S.; Brimble, M. A. Org.
Lett. 2009, 11, 563–566. (n) Joyasawal, S.; Lotesta, S. D.; Akhmedov,
N. G.; Williams, L. J. Org. Lett. 2010, 12, 988–991. (o) Canterbury,
D. P.; Micalizio, G. C. Org. Lett. 2011, 13, 2384–2387.
(7) Chae, H. D.; Kim, B. M.; Yun, U. J.; Shin, D. Y. Oncogene 2008,
27, 4115–4121.
r
10.1021/ol302751b
Published on Web 10/26/2012
2012 American Chemical Society